Why Corporate Travel Management, Kingsgate, Liontown, and Neuren shares are racing higher

These ASX shares are ending the week on a positive note.

| More on:
a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a small gain. In afternoon trade, the benchmark index is up 0.2% to 6,978.3 points.

Four ASX shares that are climbing more than most today are listed below. Here's why they are rising:

Corporate Travel Management Ltd (ASX: CTD)

The Corporate Travel Management share price is up almost 4% to $17.37. This may have been driven by a broker note out of Morgan Stanley. It has retained its overweight rating and $28.00 price target. The broker feels the market is being too negative and believes the company can achieve its guidance in FY 2023.

Kingsgate Consolidated Limited (ASX: KCN)

The Kingsgate share price has jumped 17% to $1.77. Investors have been buying this gold miner's shares after it announced the official reopening of its Chatree mine in Thailand. This follows the granting of approval from the Department of Primary Industries and Mines. Management described it as "a truly remarkable moment."

Liontown Resources Ltd (ASX: LTR)

The Liontown share price is up 4% to $1.59. This is despite there being no news out of the lithium developer. However, it is worth noting that a number of lithium shares are climbing today. Some investors may believe a buying opportunity has opened up following heavy declines in recent sessions.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is up a further 8% to $13.40. This biotech company's shares have been on fire this week thanks to news that its treatment for Rett's Syndrome has been granted US FDA approval. This is the first and only approved treatment for the rare genetic neurological and developmental disorder that affects the way the brain develops. It is expected to be available by the end of April 2023.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today

These shares are ending the week on a high. But why?

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy Thursday for ASX investors.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why BHP, DroneShield, Lotus Resources, and Nuix shares are pushing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day for the ASX.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why 4DMedical, Dateline, Predictive Discovery, and Wildcat shares are racing higher

These shares are having a good session on hump day. But why?

Read more »